tirzepatide versus semaglutide once weekly SURPASS 2: Once-Weekly Early Dose Escalation of Tirzepatide

The impact extends beyond grocery retail into restaurants and hospitality, signaling that demand softness is spreading across the broader food ecosystem

Epub 2019 Jun 5

2026 Clinical Evidence on Hepatic Fat Reduction Recent clinical data from 2026 shows semaglutide users experienced measurable reductions in hepatic steatosisthe accumulation of fat droplets inside liver cells

E.LonguetC.YustaB.CampbellJ

The information communicated by peptides is not limited to metabolic diseases, but also includes processes such as pain, immune modulation and cognitive effects

Regular monitoring of weight, blood pressure, and relevant laboratory parameters (such as hemoglobin A1c in diabetic patients) provides objective feedback on treatment response